...that allow researchers to use interfering RNA throughout the discovery process. Through its purchase of Sequitur Inc....
...sense strand of double-stranded RNA that is delivered to the cell. According to Zahl, In Sequitur's...

...IVGN acquired Sequitur, including its Stealth next-generation synthetic RNAi technology for target discovery and validation. Financial...
...products, which are based on synthetic short interfering RNA (siRNA). Invitrogen Corp. (IVGN), Carlsbad, Calif. Sequitur Inc....

...IVGN acquired Sequitur (Natick, Mass.), including its Stealth next-generation synthetic RNAi technology for target discovery and...

...and develop RNAi-based therapeutics. Under the deal, the companies will cross-license respective related technologies, including Sequitur's...
...technology and Intradigm's TSGV in vivo nucleic acid delivery technology. Intradigm Corp. , Rockville, Md. Sequitur Inc....

...Intradigm (Rockville, Md.) and Sequitur (Natick, Mass.) partnered to research and develop RNAi-based therapeutics. Under the...
...and develop RNAi-based therapeutics. Under the deal, the companies will cross-license respective related technologies, including Sequitur's...

...in sequence-specific inhibition of gene expression. The company said its product avoids degradation by nucleases. Sequitur Inc....

...The companies renewed and expanded their 2001 deal for Sequitur to conduct biological screens and supply...
...areas (see BioCentury, Oct. 15, 2001). As expanded, the deal will include additional therapeutic areas. Sequitur Inc....

...The companies extended a 2001 deal under which Sequitur is performing biological screening and supplying its...
...antisense compounds to BMY for use in the pharma company's functional genomics-based target validation efforts. Sequitur Inc....

...Sequitur will provide antisense/RNAi compounds and methods to DNA for target validation studies. Sequitur said antisense/RNAi...
...small molecule drug targets by inhibiting gene expression. Genentech Inc. (DNA), South San Francisco, Calif. Sequitur Inc....

...Sequitur (Natick, Mass.) will provide antisense/RNAi compounds and methods to DNA for target validation studies. Sequitur's...